[Study on Risk Assessment Model of in Diagnostic Reagent Adverse Events Based on BP Neural Network].

Journal: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation
PMID:

Abstract

OBJECTIVE: To modify the monitoring process and means of adverse events diagnostic reagents,improve the quantity and quality of adverse events reported ,and reduce the workload of regulatory authorities,eventually ensure the safety and effectiveness of diagnostic reagents.

Authors

  • Qing Zhu
    Zhejiang Pharmaceutical College, Ningbo, 15100.
  • Jing Ding
    Zhejiang Pharmaceutical College, Ningbo, 15100.
  • Wenxia Ren
    Zhejiang Pharmaceutical College, Ningbo, 15100.
  • Yangdui Mao
    Zhejiang Pharmaceutical College, Ningbo, 15100.
  • Wen Wang
    Clinical and Research Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.